Financial Statements

Sartorius Stedim Biotech S.A. (DIM.PA)

307.5 €

-0.10 (-0.03%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 1,210909786622-
Net Income 414358235208161
Stock Dividends -156-25-60-1500
Dividend Paid -63-31-53-42-39
Retained Earnings 1,4061,210909786622

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 644547436331-
Annual Depreciation 284257247281458
Capital Expenditure --159-136-177-127
Net PPE 928644547436331

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -386385427875
New Purchases -----324
Intangible and Goodwill 386385427875821

Sartorius Stedim Biotech S.A. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Sartorius Stedim Biotech S.A. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.